Cathie Wood Editas Medicine, Inc. Transaction History

Ark Investment Management LLC

$10.5 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 24, 2023	SELL	$8.32 - $13.21 $1.21 Million - $1.92 Million	-145,275 Reduced 99.99%	17 $0
Q3 2022 Oct 17, 2022	SELL	$12.16 - $19.42 $1.31 Million - $2.1 Million	-108,034 Reduced 42.65%	145,292 $1.78 Million
Q2 2022 Jul 11, 2022	SELL	$9.99 - $21.35 $5.43 Million - $11.6 Million	-543,915 Reduced 68.22%	253,326 $2.89 Million
Q1 2022 Apr 19, 2022	SELL	$14.08 - $27.63 $48.2 Million - $94.5 Million	-3,421,061 Reduced 81.1%	797,241 $15.2 Million
Q4 2021 Jan 28, 2022	SELL	$26.55 - $40.57 $55.2 Million - $84.3 Million	-2,079,057 Reduced 33.01%	4,218,302 $112 Million
Q3 2021 Nov 12, 2021	SELL	$39.27 - $72.94 $34.7 Million - $64.4 Million	-882,696 Reduced 12.29%	6,297,359 $259 Million
Q2 2021 Aug 05, 2021	SELL	$31.29 - $56.64 $49.2 Million - $89 Million	-1,571,868 Reduced 17.96%	7,180,055 $407 Million
Q1 2021 May 13, 2021	SELL	$39.71 - $90.58 $54.5 Million - $124 Million	-1,373,641 Reduced 13.57%	8,751,923 $368 Million
Q4 2020 Feb 12, 2021	SELL	$27.07 - $84.35 $14.7 Million - $46 Million	-544,860 Reduced 5.11%	10,125,564 $710 Million
Q3 2020 Oct 30, 2020	BUY	$28.06 - $37.16 $87.7 Million - $116 Million	3,124,278 Added 41.4%	10,670,424 $299 Million
Q2 2020 Aug 11, 2020	BUY	$18.5 - $34.34 $40.9 Million - $75.9 Million	2,210,205 Added 41.42%	7,546,146 $223 Million
Q1 2020 May 14, 2020	BUY	$14.88 - $32.78 $13.2 Million - $29.1 Million	888,664 Added 19.98%	5,335,941 $106 Million
Q4 2019 Jan 31, 2020	SELL	$19.49 - $32.63 $9.46 Million - $15.8 Million	-485,121 Reduced 9.84%	4,447,277 $132 Million
Q3 2019 Nov 12, 2019	BUY	$22.49 - $26.81 $1.89 Million - $2.26 Million	84,250 Added 1.74%	4,932,398 $112 Million
Q2 2019 Jul 30, 2019	BUY	$20.48 - $27.76 $5.91 Million - $8.01 Million	288,714 Added 6.33%	4,848,148 $120 Million
Q1 2019 May 13, 2019	BUY	$19.43 - $26.41 $29.8 Million - $40.5 Million	1,534,945 Added 50.75%	4,559,434 $111 Million
Q4 2018 Feb 01, 2019	BUY	$18.19 - $31.79 $4.2 Million - $7.33 Million	230,635 Added 8.26%	3,024,489 $68.8 Million
Q3 2018 Nov 07, 2018	BUY	$27.65 - $38.39 $16.9 Million - $23.5 Million	612,282 Added 28.07%	2,793,854 $88.9 Million
Q2 2018 Aug 07, 2018	BUY	$31.4 - $41.01 $17.6 Million - $23 Million	561,364 Added 34.65%	2,181,572 $78.2 Million
Q1 2018 May 14, 2018	BUY	$29.84 - $44.08 $15.1 Million - $22.4 Million	507,363 Added 45.59%	1,620,208 $53.7 Million
Q4 2017 Feb 12, 2018	BUY	$21.89 - $31.34 $9.3 Million - $13.3 Million	424,975 Added 61.78%	1,112,845 $34.2 Million
Q3 2017 Nov 09, 2017	BUY	$15.81 - $24.01 $2.81 Million - $4.27 Million	177,683 Added 34.83%	687,870 $16.5 Million
Q2 2017 Aug 11, 2017	BUY	N/A	280,265 Added 121.9%	510,187 $8.56 Million
Q1 2017 May 15, 2017	BUY	N/A	229,922	229,922 $5.13 Million

Others Institutions Holding EDIT

# of Institutions

248

Shares Held

57M

Call Options Held

410K

Put Options Held

394K

Black Rock Inc. New York, NY

7.78M
Shares

$10.2 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

6.68M
Shares

$8.75 Million
0.0% of portfolio
Deep Track Capital, LP Greenwich, CT

4.9M
Shares

$6.42 Million
0.62% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

3.35M
Shares

$4.39 Million
0.01% of portfolio
State Street Corp Boston, MA

2.46M
Shares

$3.23 Million
0.0% of portfolio

View Full List

About Editas Medicine, Inc.

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $90M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

More about EDIT

Track Cathie Wood's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ark Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ark Investment Management LLC and Cathie Wood with notifications on news.

Account